NuVasive Inc. (NUVA)

62.05 -6.2 (-9.084%)

IEX Real-Time Price

October 19, 2018 EST.

Nasdaq Global Select : Healthcare

Prev Close 68.25

Price Open 67.5

Volume: 2.23M

Avg Volume: 579,744

Market Cap: 3.19B

P/E Ratio 30.27

52 Wk Range 44.62-72.41



NUVA Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-09-28
47.39M
4.92M
9.36
10.38%

2018-09-14
47.39M
5.2M
9.88
10.97%

2018-08-31
47.39M
5.37M
7.21
11.32%

2018-08-15
47.4M
6.49M
8.38
13.69%




NUVA Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-07-31
Q2 2018
AMC
0.58 (9)
0.58
0.00

2018-05-01
Q1 2018
AMC
0.45 (10)
0.39
-0.06

2018-04-24
Q1 2018
N/A
0.45 (10)
0.39
-0.06

2018-02-26
Q4 2017
AMC
0.56 (9)
0.39
-0.06

News

NuVasive names J. Christopher Barry as CEO (2018-10-19 08:42 SeekingAlpha)

NuVasive (NASDAQ: NUVA ) has named J. Christopher Barry to succeed Gregory T. Lucier as Chief Executive Officer, effective November 5.Mr. Barry will join the Board of Directors; Mr. Lucier will continue to serve as chairman of the Board. More news on: NuVasive, Inc., Healthcare sto…

 

NuVasive Names J. Christopher Barry To Succeed Gregory T. Lucier As Chief Executive Officer; Lucier To Remain Chairman Of The Board (2018-10-19 08:30 PR Newswire)

SAN DIEGO , Oct. 19, 2018 /PRNewswire/ --NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced its Board of Directors has named J. Christopher Bar…

 


Statistics

Shares Outstanding: 51.42M

Top 15 Institution Percent: N/A

Price To Sales: 4.36

Price To Book: 4.54

Revenue: 247.43M

Gross Profit: 181.85M

Cash: 62.20M

Debt: 618.19M

Return On Assets: 2.58

Return On Equity: 5.65

Profit Margin: 0.76

Price History

Beta: 0.52

50-day Moving Avg: 69.06

200-day Moving Avg: 56.49

YTD Change: 11.37

5-day Change: 3.80

1-month Change: -3.12

3-month Change: 28.43

6-month Change: 29.09

1-year Change: 25.97

Revenue Per Share: 5.00

Revenue Per Employee: 130227.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: NuVasive Inc.

Exchange: Nasdaq Global Select

Industry: Medical Devices

Sector: Healthcare

Website: http://www.nuvasive.com

NuVasive Inc is a medical device company. It develops minimally-disruptive surgical products and procedurally-integrated solutions for the spine. Its product portfolio is focused on applications for spine fusion surgery.